Eli Lilly’s Zepbound, Mounjaro in short supply through June, FDA says 

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. Brendan McDermid | ReutersMost doses of Eli Lilly's highly popular weight loss drug Zepbound and diabetes counterpart Mounjaro will be in short supply through the second quarter of this year...

Read more...

Pfizer RSV vaccine may protect high-risk adults ages 18-59

Respiratory syncytial virus - viral vaccine under researchHailshadow | Istock | Getty ImagesA vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk of getting severely sick from respiratory syncytial virus in a late stage clinical trial, the company said Tuesday.The...

Read more...

Drug similar to Ozempic slowed Parkinson’s disease in small trial

The coronal view of a human brain of a patient suffering from Parkinson's diseaseSherbrooke Connectivity Imaging Lab | Getty ImagesA highly popular class of drugs for diabetes and obesity is showing early potential to help patients with Parkinson's disease, too. An older diabetes treatment called lixisenatide helped slow the progression...

Read more...

Health insurer stocks slide as Medicare Advantage rates disappoint

Signage is displayed on a Humana Inc. office building in Louisville, Kentucky, U.S., on Saturday, Feb. 2, 2019. Humana is scheduled to release earnings figures on February 6.Luke Sharrett | Bloomberg | Getty ImagesShares of U.S. health insurers fell Tuesday after the Biden administration didn't boost payments for private...

Read more...